跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 351 条关于
“Versamune MUC1”
全部
351
临床试验
170
药物
125
机构
1
资讯
55
去年
FDA Clears PDS Biotech's Novel Immunotherapy Combination for Metastatic Colorectal Cancer Trial
9个月前
PDS Biotechnology Secures New Japanese Patent for Cancer Immunotherapy PDS0101, Extending Protection Into 2040s
去年
PDS Biotech's Versamune Shows Promise in HPV-Positive Cancers
去年
Minerva Biotechnologies Advances MUC1*-Targeted CAR-T Therapy with 1XX Mutations for Solid Tumors
去年
Versamune HPV Vaccine Plus Pembrolizumab Shows Promise in HPV16+ Head and Neck Cancer
3个月前
South African Scientists Decode How Cancer Rewires MUC1 Sugar Coating to Evade the Immune System
去年
Versamune® HPV Shows Promising ctDNA Clearance and Survival Rates in Advanced Cervical Cancer Trial
去年
PDS Biotechnology's Versamune HPV Shows 30-Month Median Survival in Phase 2 Head and Neck Cancer Trial
去年
Versamune HPV Shows Promising Survival Rates in Advanced Cervical Cancer Trial
去年
PDS Biotech's Versamune HPV Shows Promise in HPV16-Positive Cancers, Phase III Trial Planned
第 1 页,共 6 页
上一页
下一页